|
|
|
|
Дата |
|---|
| 16.07.2026 |
| 15.07.2026 |
| 14.07.2026 |
| 13.07.2026 |
| 12.07.2026 |
| 09.07.2026 |
| 08.07.2026 |
| 07.07.2026 |
| 06.07.2026 |
| 05.07.2026 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
88.09
|
97.25
|
105.70
|
105.70
|
|
|
32 846 561.50
|
761.00
|
|
|
|
73.41
|
73.23
|
88.09
|
88.09
|
|
|
47 191 537.04
|
1 212.00
|
|
|
|
74.79
|
73.00
|
74.79
|
73.41
|
|
|
2 638 829.69
|
225.00
|
|
|
|
73.60
|
73.15
|
75.46
|
74.79
|
|
|
4 627 361.86
|
261.00
|
|
|
|
73.60
|
73.50
|
74.70
|
73.60
|
|
|
2 054 762.98
|
180.00
|
|
|
|
73.24
|
73.34
|
75.49
|
73.60
|
|
|
4 128 859.87
|
241.00
|
|
|
|
72.02
|
71.60
|
76.95
|
73.24
|
|
|
15 817 873.95
|
615.00
|
|
|
|
72.09
|
71.90
|
72.50
|
72.02
|
|
|
1 542 102.56
|
158.00
|
|
|
|
70.57
|
70.61
|
73.11
|
72.09
|
|
|
2 356 011.79
|
197.00
|
|
|
|
71.48
|
70.03
|
72.98
|
70.57
|
|
|
2 722 236.60
|
258.00
|
Период |
|---|
| 2025, регулярные |
| 2022, регулярные |
| 2022, регулярные |
| 2019, регулярные |
| 2018, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2014, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
08.01.2026
|
11.01.2026 |
1 EGP |
|
25.06.2023
|
03.07.2023 |
0.75 EGP |
|
02.01.2023
|
03.01.2023 |
3 EGP |
|
28.08.2020
|
31.08.2020 |
0.5 EGP |
|
01.12.2019
|
02.12.2019 |
0.5 EGP |
|
24.12.2017
|
25.12.2017 |
0.5 EGP |
|
11.11.2016
|
14.11.2016 |
0.5 EGP |
|
08.07.2015
|
09.07.2015 |
0.5 EGP |
|
24.05.2012
|
27.05.2012 |
0.75 EGP |
|
03.06.2011
|
06.06.2011 |
0.75 EGP |
GlaxoSmithKline SAE, a member of Glaxo Group Limited (Britain), is an Egypt-based company engaged in manufacturing, packaging, marketing, sale and distribution of pharmaceutical products.
